Markets Share Share this article Copy linkX (Twitter)LinkedInFacebookEmail Core Scientific turns lower after Q4 results Markets Share Share this article Copy linkX (Twitter)LinkedInFacebookEmail Core Scientific turns lower after Q4 results

Core Scientific turns lower after Q4 results disappoint

2026/03/03 05:38
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail

Core Scientific turns lower after Q4 results disappoint

Riot Platforms topped revenue estimates as it reported earnings for the final three months of 2025.

By James Van Straten, Helene Braun|Edited by Stephen Alpher
Mar 2, 2026, 9:38 p.m.
Make us preferred on Google

What to know:

  • Core Scientific reported fourth-quarter revenue of $79.8 million, missing Wall Street expectations, and widening its loss to $0.42 per share.
  • The company is shifting its focus toward hosting and colocation for high-performance computing and AI, expanding its power capacity by about 730 megawatts, including a major push into Texas.
  • Riot Platforms posted a sharp jump in fourth-quarter revenue to $647.4 million, far above forecasts, though its shares and Core Scientific’s traded little changed in after-hours trading.

Core Scientific (CORZ), a bitcoin mining and digital infrastructure company, reported fourth-quarter revenue of $79.8 million for the period ended Dec. 31, compared with $94.93 million a year earlier. Consensus forecasts were for revenue of $122.08 million, according to LSEG data.

The company posted a loss of $0.42 per share, versus expectations for a loss of $0.08 per share.

The weaker results come as bitcoin miners continue to adjust to the April 2024 halving, which cut block rewards in half and squeezed margins across the industry. A higher network hash rate and rising energy and infrastructure costs have pressured profitability, particularly for operators still scaling new capacity.

Core has been repositioning itself beyond pure self-mining and toward hosting and colocation services for high-performance computing clients, including AI workloads. CEO Adam Sullivan said the company is leaning into that strategy.

“We’re now past the halfway point on our existing builds and scaling our colocation platform into a 1.5 gigawatt pipeline of leasable capacity,” Core Scientific CEO Adam Sullivan, said in a statement. “With a multi-geography footprint and proven execution, we’re accelerating RFS timelines across multiple sites to position the company for durable growth.”

As part of this plan, the company announced that it is expanding into Texas, adding about 430 mega watts of gross power capacity. It also increased capacity across other regions by about 300 mega watts.

CORZ shares were lower by 4.5% in after hours trading.

Meanwhile, Riot Platforms (RIOT), a bitcoin mining and data center development company, reported fourth-quarter revenue of $647.4 million, up from $376.7 million a year earlier. Analysts had expected revenue of $157.4 million, including $136 million from bitcoin mining and $21.3 million from engineering.

RIOT shares were flat after hours.

Bitcoin NewsCore ScientificRiot Blockchain

More For You

Bitcoin’s 5% spike higher Monday driven by short-covering, not fresh buying, says analyst

Market data show rising open interest and large liquidation clusters around $65,000 and above $70,000, underscoring that the rally may be fragile without stronger spot demand

What to know:

  • Bitcoin shook off a weekend slump, rising nearly 5% on Monday to above $69,000.
  • An analyst says the move was driven largely by a short squeeze and leveraged positioning, aided by macro turmoil and a reversal of outflows from spot bitcoin ETFs.
  • Market data show rising open interest and large liquidation clusters around $65,000 and above $70,000, underscoring that the rally may be fragile without stronger spot demand.
Read full story
Latest Crypto News

Bitcoin’s 5% spike higher Monday driven by short-covering, not fresh buying, says analyst

Vitalik Buterin unveils plan to curb Ethereum block builder centralization

Battle for Bitcoin's soul opens as first block supporting 'clean-up' proposal is mined

Weekend warriors: How HyperLiquid became retail’s bear market playground

Crypto world faces growing pressure to relent on stablecoin rewards to win bigger prize

Nasdaq follows Cboe joining world of 'binary bets' as prediction market craze hits Wall Street

Top Stories

Bitcoin surges above $68,000 amid muted stock market reaction to Iran war

Tom Lee's Bitmine boosts ether holdings to 4.47 million tokens with $98 million ETH purchase

Strategy purchased more than $200 million in bitcoin last week

Iranian crypto outflows jump 700% minutes after U.S.-Israeli airstrikes, Elliptic says

Battered bitcoin could find solace in war-led 'debasement' trade

SpaceX’s $780 million bitcoin stack now down to about $545 million ahead of IPO filing

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09